Familial knockin mutation of LRRK2 causes lysosomal dysfunction and accumulation of endogenous insoluble α-synuclein in neurons J Schapansky, S Khasnavis, MP DeAndrade, JD Nardozzi, SR Falkson, ... Neurobiology of disease 111, 26-35, 2018 | 131 | 2018 |
Motor restlessness, sleep disturbances, thermal sensory alterations and elevated serum iron levels in Btbd9 mutant mice MP DeAndrade, RL Johnson Jr, EL Unger, L Zhang, T van Groen, ... Human molecular genetics 21 (18), 3984-3992, 2012 | 93 | 2012 |
Characterization of Atp1a3 mutant mice as a model of rapid-onset dystonia with parkinsonism MP DeAndrade, F Yokoi, T van Groen, JB Lingrel, Y Li Behavioural brain research 216 (2), 659-665, 2011 | 84 | 2011 |
Lysosome and Inflammatory Defects in GBA1‐Mutant Astrocytes Are Normalized by LRRK2 Inhibition A Sanyal, MP DeAndrade, HS Novis, S Lin, J Chang, N Lengacher, ... Movement disorders 35 (5), 760-773, 2020 | 83 | 2020 |
Altered Dendritic Morphology of Purkinje cells in Dyt1 ΔGAG Knock-In and Purkinje Cell-Specific Dyt1 Conditional Knockout Mice L Zhang, F Yokoi, YH Jin, MP DeAndrade, K Hashimoto, DG Standaert, ... PLoS One 6 (3), e18357, 2011 | 80 | 2011 |
Engineering animal models of dystonia J Oleas, F Yokoi, MP DeAndrade, A Pisani, Y Li Movement Disorders 28 (7), 990-1000, 2013 | 59 | 2013 |
Earlier onset of motor deficits in mice with double mutations in Dyt1 and Sgce F Yokoi, G Yang, JD Li, MP DeAndrade, T Zhou, Y Li The journal of biochemistry 148 (4), 459-466, 2010 | 44 | 2010 |
Enhanced hippocampal long-term potentiation and fear memory in Btbd9 mutant mice MP DeAndrade, L Zhang, A Doroodchi, F Yokoi, CC Cheetham, HX Chen, ... PLoS One 7 (4), e35518, 2012 | 35 | 2012 |
The role of BTBD9 in striatum and restless legs syndrome S Lyu, H Xing, MP DeAndrade, Y Liu, PD Perez, F Yokoi, M Febo, ... Eneuro 6 (5), 2019 | 25 | 2019 |
Electromyographic evidence in support of a knock‐in mouse model of DYT1 Dystonia MP DeAndrade, A Trongnetrpunya, F Yokoi, CC Cheetham, N Peng, ... Movement Disorders 31 (11), 1633-1639, 2016 | 23 | 2016 |
Hyperactivity, dopaminergic abnormalities, iron deficiency and anemia in an in vivo opioid receptors knockout mouse: Implications for the restless legs syndrome S Lyu, MP DeAndrade, S Mueller, A Oksche, AS Walters, Y Li Behavioural brain research 374, 112123, 2019 | 21 | 2019 |
The role of BTBD9 in the cerebellum, sleep-like behaviors and the restless legs syndrome S Lyu, H Xing, MP DeAndrade, PD Perez, F Yokoi, M Febo, AS Walters, ... Neuroscience 440, 85-96, 2020 | 19 | 2020 |
The role of BTBD9 in the cerebral cortex and the pathogenesis of restless legs syndrome S Lyu, H Xing, MP DeAndrade, PD Perez, K Zhang, Y Liu, F Yokoi, ... Experimental neurology 323, 113111, 2020 | 18 | 2020 |
BTBD9 and dopaminergic dysfunction in the pathogenesis of restless legs syndrome S Lyu, A Doroodchi, H Xing, Y Sheng, MP DeAndrade, Y Yang, ... Brain Structure and Function 225, 1743-1760, 2020 | 15 | 2020 |
Mu opioid receptor knockout mouse: Phenotypes with implications on restless legs syndrome S Lyu, MP DeAndrade, EL Unger, S Mueller, A Oksche, AS Walters, Y Li Journal of neuroscience research 98 (8), 1532-1548, 2020 | 11 | 2020 |
High-throughput analysis of hematopoietic stem cell engraftment after intravenous and intracerebroventricular dosing RN Plasschaert, MP DeAndrade, F Hull, Q Nguyen, T Peterson, A Yan, ... Molecular Therapy 30 (10), 3209-3225, 2022 | 8 | 2022 |
Rodent models of autosomal dominant primary dystonia J Oleas, F Yokoi, MP DeAndrade, Y Li Movement Disorders, 483-505, 2015 | 7 | 2015 |
Btbd9 knockout mice as a model of restless legs syndrome MP DeAndrade, Y Li Movement Disorders, 1191-1205, 2015 | 6 | 2015 |
Probing the relationship between BTBD9 and MEIS1 in C. elegans and mouse S Lyu, A Doroodchi, Y Sheng, MP DeAndrade, Y Yang, Y Liu, MA Miller, ... Experimental results 1, e8, 2020 | 2 | 2020 |
Compositions and methods for treating neurocognitive disorders C Mason, O Cooper, M Deandrade, R Plasschaert, NPN VAN TIL US Patent App. 17/427,298, 2022 | 1 | 2022 |